NCT01815827View on ClinicalTrials.gov

A Study of Single Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Healthy Volunteer
Interventions
DRUG

inclacumab

single intravenous doses

Trial Locations (1)

92801

Anaheim

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01815827 - A Study of Single Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy Volunteers | Biotech Hunter | Biotech Hunter